Literature DB >> 70072

Population data on two new HLA-D determinants, EI and RE.

H Grosse-Wilde, G Hauptmann, R Johannsen, B Netzel, C Rittner, W Ruppelt.   

Abstract

Homozygous typing cells (HTC) for two new HLA-D determinants, EI and RE, defined by family studies, are described. The HLA-D typing experiments among more than 300 unrelated individuals showed phenotype frequencies of 0.045 for EI and 0.098 for RE. Since the tested population was also typed for its HLA-A and -B alleles, linkage disequilibrium parameters could be calculated: HLA-D type EI was statistically significantly associated with HLA-B13 and Bw17, HLA-D type RE with HLA-Bw40. These data support the working hypothesis that both EI and RE are new alleles of the HLA-D series.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70072     DOI: 10.1111/j.1365-3083.1977.tb02114.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

Review 1.  Genetic loci of components of the classical and alternate pathway of complement activation: a new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man.

Authors:  C Rittner
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

2.  Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.

Authors:  B S Nepom; G T Nepom; E Mickelson; P Antonelli; J A Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

3.  Association of low C2 and C4 serum levels with the HLA-DW2 allele in healthy individuals.

Authors:  C Nerl; H Grosse-Wilde; G Valet
Journal:  J Exp Med       Date:  1978-09-01       Impact factor: 14.307

4.  The HLA-DR4 family of haplotypes consists of series of distinct DR and DS molecules.

Authors:  G T Nepom; B S Nepom; P Antonelli; E Mickelson; J Silver; S M Goyert; J A Hansen
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.